arrow
L

Lluís Ballell

glaxosmithkline spain
H指数:38
被引数:3,989

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis

Alpibectir–Ethionamide组合(AlpE)用于治疗结核病

2026-04-070
OAAI
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens

细胞色素bc1抑制剂的未来结核病治疗方案中的作用

2025-10-220
OAAI
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis

在结核病小鼠模型中,贝达喹啉或TBAJ-587联合GSK2556286及TBA-7371的新方案的杀菌与灭菌活性

2024-04-036
OAAI
Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes

<i>Delftia tsuruhatensis</i> TC1共生体抑制按蚊蚊子传播疟疾

Science
IF45.8
2023-01-010
OA
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment
2022-06-2128
OA
The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis

小分子SMARt751在急性和慢性结核病小鼠模型中逆转结核分枝杆菌对乙硫酰胺的耐药性

2022-05-0419
OA
Repurposing Infectious Disease Hits as Anti-Cryptosporidium Leads
2021-03-1910
OA
MymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against Mycobacterium tuberculosis
2020-04-1011
OAAI
Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening (vol 8, pg 16081, 2017)
2018-07-134
OAAI